Bristol Myers Squibb: Unloved & Underappreciated

(Video length 00:12:39)

Bristol-Myers Squibb is a leading pharmaceutical company with a strong pipeline. However, the stock is been stagnant in 2020 and therefore remains significantly undervalued here at the beginning of 2021. With this video, I attempt to illustrate reasons why the market has been neglecting this blue-chip and then elaborate on whether it is justified or not.

 

 

Disclosure: Long BMY.

Disclaimer: The opinions in this article are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.